Obesity and obesity-related diseases including insulin resistance and metabolic syndrome (MetS) pose a great risk for cardiovascular disease development. Skeletal muscle as an endocrine organ has pivotal role on secreting physiological factors such as hormones and myokines. Irisin that is one of these myokines also known as hormone is secreted mainly from muscle tissue in response to exercise. It is dependent to fibronectin type III-containing protein 5 (FNDC5) that is a membrane protein and encoded by FNDC5 gene. After discovering of FNDC5, metabolic effects of irisin have been investigated so far. Irisin has mainly effects on muscle, adipose tissue, pancreas, liver, nervous system and bone. In studies conducted to date, obtained findings regarding the relationship of irisin status with obesity, insulin resistance and MetS are contradictory. Although irisin concentration was found higher in individuals with metabolic disorders in some studies, lower irisin concentration were observed in some other studies. Additionally, any receptors for irisin molecule hasn't yet discovered. Therefore, it is thought that the discovery of irisin molecule receptors and the determining of the tissues where these receptors are localized will be useful in understanding the mechanism of action of the irisin. In this review, we aimed to investigate potential effects of irisin on obesity, insulin resistance and MetS and additionally to examine underlying mechanisms of the association between circulating irisin and metabolic disorders.